These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 21137075)

  • 1. Focus on cancer proteomics: from discovery towards validation.
    Gallagher WM
    Proteomics Clin Appl; 2010 Jul; 4(6-7):577-8. PubMed ID: 21137075
    [No Abstract]   [Full Text] [Related]  

  • 2. Implications of salivary proteomics in drug discovery and development: a focus on cancer drug discovery.
    Hu S; Yen Y; Ann D; Wong DT
    Drug Discov Today; 2007 Nov; 12(21-22):911-6. PubMed ID: 17993408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proteomics and biomarkers for ovarian cancer diagnosis.
    Zhang B; Barekati Z; Kohler C; Radpour R; Asadollahi R; Holzgreve W; Zhong XY
    Ann Clin Lab Sci; 2010; 40(3):218-25. PubMed ID: 20689132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statistical data processing in clinical proteomics.
    Smit S; Hoefsloot HC; Smilde AK
    J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Apr; 866(1-2):77-88. PubMed ID: 18033744
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarker discovery in lung cancer--promises and challenges of clinical proteomics.
    Bharti A; Ma PC; Salgia R
    Mass Spectrom Rev; 2007; 26(3):451-66. PubMed ID: 17407130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry-based clinical proteomics: head-and-neck cancer biomarkers and drug-targets discovery.
    Matta A; Ralhan R; DeSouza LV; Siu KW
    Mass Spectrom Rev; 2010; 29(6):945-61. PubMed ID: 20945361
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteomics: new technologies and clinical applications.
    Latterich M; Abramovitz M; Leyland-Jones B
    Eur J Cancer; 2008 Dec; 44(18):2737-41. PubMed ID: 18977654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteomics in prostate cancer biomarker discovery.
    Larkin SE; Zeidan B; Taylor MG; Bickers B; Al-Ruwaili J; Aukim-Hastie C; Townsend PA
    Expert Rev Proteomics; 2010 Feb; 7(1):93-102. PubMed ID: 20121479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomic approaches for serum biomarker discovery in cancer.
    Maurya P; Meleady P; Dowling P; Clynes M
    Anticancer Res; 2007; 27(3A):1247-55. PubMed ID: 17593616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in ovarian cancer proteomics: the quest for biomarkers and improved therapeutic interventions.
    Jurisicova A; Jurisica I; Kislinger T
    Expert Rev Proteomics; 2008 Aug; 5(4):551-60. PubMed ID: 18761466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomics-driven cancer biomarker discovery: looking to the future.
    Simpson RJ; Bernhard OK; Greening DW; Moritz RL
    Curr Opin Chem Biol; 2008 Feb; 12(1):72-7. PubMed ID: 18295612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Casting light on molecular events underlying anti-cancer drug treatment: what can be seen from the proteomics point of view?
    Kraljevic S; Sedic M; Scott M; Gehrig P; Schlapbach R; Pavelic K
    Cancer Treat Rev; 2006 Dec; 32(8):619-29. PubMed ID: 17069979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of human plasma proteins: a focus on sample collection and separation using free-flow electrophoresis.
    Nissum M; Foucher AL
    Expert Rev Proteomics; 2008 Aug; 5(4):571-87. PubMed ID: 18761468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The discovery and validation of colorectal cancer biomarkers.
    Ang CS; Phung J; Nice EC
    Biomed Chromatogr; 2011 Jan; 25(1-2):82-99. PubMed ID: 21058408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary proteomics based on capillary electrophoresis-coupled mass spectrometry in kidney disease: discovery and validation of biomarkers, and clinical application.
    Mischak H; Delles C; Klein J; Schanstra JP
    Adv Chronic Kidney Dis; 2010 Nov; 17(6):493-506. PubMed ID: 21044772
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current advances in tumor proteomics and candidate biomarkers for hepatic cancer.
    Peng XQ; Wang F; Geng X; Zhang WM
    Expert Rev Proteomics; 2009 Oct; 6(5):551-61. PubMed ID: 19811076
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-throughput proteomics of breast carcinoma cells: a focus on FTICR-MS.
    Umar A; Jaremko M; Burgers PC; Luider TM; Foekens JA; Pasa-Tolic L
    Expert Rev Proteomics; 2008 Jun; 5(3):445-55. PubMed ID: 18532912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biomarkers discovery in cancer--up-dates in methodology.
    Tacu C; Neagu M; Constantin C; Sajin M
    Roum Arch Microbiol Immunol; 2010; 69(1):48-55. PubMed ID: 21053784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.